Explore Business Standard
Associate Sponsors
Co-sponsor
Wearing a PPE kit, Prime Minister Narendra Modi reviewed the vaccine development process at the Zydus Cadila research centre in Changodar industrial area, over 20 km from Ahmedabad. Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D is over and it has commenced phase-II clinical trials from August. In Hyderabad, Modi visited vaccine maker Bharat Biotech's facility. Bharat Biotech's Covaxin is undergoing phase-3 trials. After his hour-long visit to the facility, the PM will proceed to Pune, where he will visit the Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and the Oxford University for the vaccine.